Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DIS3 like 3'-5' exoribonuclease 2 pseudogene 1 (DIS3L2P1) is classified as a human pseudogene—an inactive genomic DNA sequence similar to the functional DIS3L2 gene, but with no current evidence for coding a protein or performing biological roles. Although named similarly to protein-coding genes involved in RNA degradation and cell cycle regulation, such as DIS3 and DIS3L2, DIS3L2P1 itself does not appear to have characterized molecular activity, is not associated with any disease phenotypes, and is not considered a pharmacological or therapeutic target[4][5][6]. If your intent is to study RNA exosome components or related therapeutic targets, refer instead to the functional gene "DIS3 like 3'-5' exoribonuclease 2 (DIS3L2)"[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DIS3 like 3'-5' exoribonuclease 2 pseudogene 1 (DIS3L2P1).